Casey McNulty Stockton, PharmD

home / authors / casey-mcnulty-stockton-pharmd

Articles

July 7th 2009

Lipid Profile Changes Associated With Changing Available Formulary Statins: Removing Higher Potency Agents

Daniel S. Longyhore, PharmD Casey McNulty Stockton, PharmD Marie Roke Thomas, PhD

With the exception of high-density lipoprotein cholesterol, fasting lipid profiles were not significantly changed after higher potency statins were removed from prescription formularies.

Latest Updated Articles

Opdivo packaging | Image credit: Bristol Myers Squibb

Published: May 9th 2024 | Updated: May 21st 2024

FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors

Published: September 12th 2024 | Updated: September 16th 2024

The American Journal of Managed Care® Announces Lisa Rotenstein, M.D., MBA, as the Recipient of the Seema S. Sonnad Emerging Leader in Managed Care Research Award

Published: April 23rd 2024 | Updated: September 16th 2024

The American Journal of Managed Care® Announces Call for Manuscript Submissions for the 14th Annual Health Information Technology Special Issue

Wegovy injections | Image credit: K KStock – stock.adobe.com

Published: August 6th 2024 | Updated: September 16th 2024

Rising Costs Lead Insurers to Drop Weight Loss Drug Coverage, Further Increasing Patient Burden

Cleveland, OH Image credit: SeanPavonePhoto – stock.adobe.com

Published: August 16th 2024 | Updated: September 16th 2024

How Can We Improve Obesity Care in 2024 and Beyond?

Diverse representation in health care materials is one of multiple factors that could benefit patient education initiatives | image credit: Fitry - stock.adobe.come

Published: September 10th 2024 | Updated: September 16th 2024

Different Options for Different People: Dr Bellinda King-Kallimanis Explores the State of Patient Education in Lung Cancer

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

Do Not Sell My Information

Terms & Conditions